USD 2.19
(6.31%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -54.76 Million USD | 9.49% |
2022 | -51 Million USD | -31.84% |
2021 | -41.28 Million USD | -11.19% |
2020 | -39.13 Million USD | 6.5% |
2019 | -43.46 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -9.81 Million USD | -3.87% |
2024 Q2 | -6.31 Million USD | 35.45% |
2023 Q1 | -14.81 Million USD | -0.35% |
2023 FY | - USD | 9.49% |
2023 Q4 | -9.4 Million USD | 41.54% |
2023 Q2 | -16.11 Million USD | -8.76% |
2023 Q3 | -16.09 Million USD | 0.1% |
2022 Q4 | -14.76 Million USD | -6.32% |
2022 Q3 | -13.88 Million USD | -2.05% |
2022 Q2 | -13.6 Million USD | 1.93% |
2022 Q1 | -13.87 Million USD | -4.17% |
2022 FY | - USD | -31.84% |
2021 Q1 | -9.05 Million USD | 14.47% |
2021 FY | - USD | -11.19% |
2021 Q4 | -13.31 Million USD | -28.97% |
2021 Q3 | -10.32 Million USD | -12.43% |
2021 Q2 | -9.18 Million USD | -1.39% |
2020 Q2 | -10.47 Million USD | 0.0% |
2020 Q1 | -10.47 Million USD | 0.0% |
2020 FY | - USD | 6.5% |
2020 Q4 | -10.59 Million USD | -22.41% |
2020 Q3 | -8.65 Million USD | 17.35% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Abbott Laboratories | 10.46 Billion USD | 100.523% |
Allurion Technologies Inc. | -69.03 Million USD | 20.662% |
Artivion, Inc. | 38.14 Million USD | 243.59% |
Avanos Medical, Inc. | 53.2 Million USD | 202.947% |
Butterfly Network, Inc. | -124.84 Million USD | 56.131% |
Butterfly Network, Inc. | -124.84 Million USD | 56.131% |
Bio-Rad Laboratories, Inc. | -608.26 Million USD | 90.996% |
Boston Scientific Corporation | 3.45 Billion USD | 101.586% |
Perspective Therapeutics, Inc. | -14.83 Million USD | -269.106% |
CONMED Corporation | 182.18 Million USD | 130.062% |
Edwards Lifesciences Corporation | 1.76 Billion USD | 103.098% |
Paragon 28, Inc. | -36.61 Million USD | -49.582% |
Glaukos Corporation | -82.11 Million USD | 33.304% |
Globus Medical, Inc. | 418.23 Million USD | 113.095% |
Inspire Medical Systems, Inc. | -17.06 Million USD | -221.032% |
Integer Holdings Corporation | 282.05 Million USD | 119.417% |
Medtronic plc | 9.05 Billion USD | 100.605% |
Nevro Corp. | -78.31 Million USD | 30.063% |
Owlet, Inc. | -27.48 Million USD | -99.236% |
Penumbra, Inc. | 111.99 Million USD | 148.902% |
Vicarious Surgical Inc. | -69.19 Million USD | 20.846% |
Smith & Nephew plc | 979 Million USD | 105.594% |
STERIS plc | 1.41 Billion USD | 103.878% |
Stryker Corporation | 5.16 Billion USD | 101.061% |
Vapotherm, Inc. | -34.35 Million USD | -59.409% |
Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 102.236% |